Abstract
Data from a descriptive study of idiopathic Parkinson's disease were analysed aimed at getting a clearer picture of the impact of the disease on the community and the help available to patients and carers. Altogether 267 patients aged 40-92 were identified, and the median duration of disease in those in whom this could be assessed was 7.2 years. Of the 267 patients, 204 (76.4%) were living in the community, 51 alone. A total of 201 patients were taking levodopa, 29 out of 102 had retired early, and 60 out of 84 (71.4%) had given up driving. Most patients had symptoms at the time of study, and signs such as bradykinesia, rigidity, impaired speech, and abnormal gait were often moderate or severe. Of 214 patients whose disease was assessed using the scoring system of Hoehn and Yahr, 78 (36.4%) had grade 4 and 23 (10.7%) grade 5 disability. Despite this, however, 105 of 265 patients (39.6%) were not subject to regular medical review and only 57 of 227 patients (25.1%) had been seen by an occupational therapist, 16 (7.0%) by a physiotherapist, and 10 (4.4%) by a speech therapist. Patients with Parkinson's disease may benefit from regular medical review and being seen by therapists.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrews K., Brocklehurst J. C. Provision of remedial therapists in geriatric medicine. Br Med J (Clin Res Ed) 1984 Sep 15;289(6446):661–661. doi: 10.1136/bmj.289.6446.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bulpitt C. J., Shaw K., Clifton P., Stern G., Davies J. B., Reid J. L. The symptoms of patients treated for Parkinson's disease. Clin Neuropharmacol. 1985;8(2):175–183. doi: 10.1097/00002826-198506000-00007. [DOI] [PubMed] [Google Scholar]
- Mutch W. J., Dingwall-Fordyce I., Downie A. W., Paterson J. G., Roy S. K. Parkinson's disease in a Scottish city. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):534–536. doi: 10.1136/bmj.292.6519.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pearce J. M. Drug treatment in Parkinson's disease. Br Med J (Clin Res Ed) 1984 Jun 16;288(6433):1777–1778. doi: 10.1136/bmj.288.6433.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scott S., Caird F. I. Speech therapy for Parkinson's disease. J Neurol Neurosurg Psychiatry. 1983 Feb;46(2):140–144. doi: 10.1136/jnnp.46.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scott S., Caird F. I. Speech therapy for patients with Parkinson's disease. Br Med J (Clin Res Ed) 1981 Oct 24;283(6299):1088–1088. doi: 10.1136/bmj.283.6299.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutcliffe R. L., Prior R., Mawby B., McQuillan W. J. Parkinson's disease in the district of the Northampton Health Authority, United Kingdom. A study of prevalence and disability. Acta Neurol Scand. 1985 Oct;72(4):363–379. doi: 10.1111/j.1600-0404.1985.tb00886.x. [DOI] [PubMed] [Google Scholar]
- Webster D. D. Critical analysis of the disability in Parkinson's disease. Mod Treat. 1968 Mar;5(2):257–282. [PubMed] [Google Scholar]